You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Draft Guideline for levels and kinds of evidence for listed medicines with indications and claims for weight loss
Consultation
This consultation closed on 3 April 2009.
Introduction
This guideline has been developed to assist sponsors of Listed complementary medicines in determining the level and kind of evidence to support indications and claims for weight loss. It should be applied as an addition to the Guidelines for Levels and Kinds of Evidence to Support Indications and Claims for Non-Registerable Medicines, including Complementary Medicines and other Listable Medicines (the Guidelines).
This Guideline will also help ensure consistency in the type and level of evidence required to support indications and claims for weight loss in Listed medicines and give consumers confidence in the medicines they choose for self-care.